NM_000251.3(MSH2):c.212-3_213del AND Lynch syndrome 1
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- May 28, 2019
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000986645.1
Allele description [Variation Report for NM_000251.3(MSH2):c.212-3_213del]
NM_000251.3(MSH2):c.212-3_213del
Condition(s)
- Name:
- Lynch syndrome 1
- Synonyms:
- COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1; MSH2-Related Hereditary Non-Polyposis Colon Cancer; Lynch syndrome I; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0007356; MedGen: C2936783; Orphanet: 144; OMIM: 120435
-
PREDICTED: Homo sapiens FA complementation group L (FANCL), transcript variant X...
PREDICTED: Homo sapiens FA complementation group L (FANCL), transcript variant X11, mRNAgi|2462574661|ref|XM_054342725.1|Nucleotide
-
E3 ubiquitin-protein ligase FANCL isoform X9 [Homo sapiens]
E3 ubiquitin-protein ligase FANCL isoform X9 [Homo sapiens]gi|2462574660|ref|XP_054198699.1|Protein
-
PREDICTED: Homo sapiens FA complementation group L (FANCL), transcript variant X...
PREDICTED: Homo sapiens FA complementation group L (FANCL), transcript variant X13, mRNAgi|2462574665|ref|XM_054342727.1|Nucleotide
-
Homo sapiens FA complementation group L (FANCL), transcript variant 5, non-codin...
Homo sapiens FA complementation group L (FANCL), transcript variant 5, non-coding RNAgi|2638412376|ref|NR_164659.2|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Jun 9, 2024